-
1
-
-
0020083379
-
Rheumatoid arthritis: Treatment with azathioprine (Imuran®). Clinical side effects and laboratory abnormalities
-
Whisnant JK, Pelkey J. Rheumatoid arthritis: treatment with azathioprine (Imuran®). Clinical side effects and laboratory abnormalities. Ann Rheum Dis 1982;41(Suppl 1):44-7.
-
(1982)
Ann Rheum Dis
, vol.41
, Issue.SUPPL. 1
, pp. 44-47
-
-
Whisnant, J.K.1
Pelkey, J.2
-
2
-
-
3242704015
-
Thiopurine methyltransferase: Should it be measured before commencing thiopurine drug therapy?
-
Sanderson J, Ansari A, Marinaki T, et al. Thiopurine methyltransferase: should it be measured before commencing thiopurine drug therapy? Ann Clin Biochem 2004;41(Pt 4):294-302.
-
(2004)
Ann Clin Biochem
, vol.41
, Issue.PART 4
, pp. 294-302
-
-
Sanderson, J.1
Ansari, A.2
Marinaki, T.3
-
3
-
-
0035871560
-
Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine
-
Evans WE, Hon YY, Bomgaars L, et al. Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine. J Clin Oncol 2001;19:2293-301.
-
(2001)
J Clin Oncol
, vol.19
, pp. 2293-2301
-
-
Evans, W.E.1
Hon, Y.Y.2
Bomgaars, L.3
-
4
-
-
0033941305
-
Screening for azathioprine toxicity: Pharmacoeconomic analysis based on a target case
-
Tavadia SM, Mydlarski PR, Reis MD, et al. Screening for azathioprine toxicity: pharmacoeconomic analysis based on a target case. J Am Acad Dermatol 2000;42:628-32.
-
(2000)
J Am Acad Dermatol
, vol.42
, pp. 628-632
-
-
Tavadia, S.M.1
Mydlarski, P.R.2
Reis, M.D.3
-
5
-
-
0036312490
-
Erythrocyte thiopurine methyltransferase assessment prior to azathiopurine use in the UK
-
Holme SA, Duley JA, Sanderson J, et al. Erythrocyte thiopurine methyltransferase assessment prior to azathiopurine use in the UK. Q J Med 2002;95:439-44.
-
(2002)
Q J Med
, vol.95
, pp. 439-444
-
-
Holme, S.A.1
Duley, J.A.2
Sanderson, J.3
-
6
-
-
0346463205
-
Relevance of thiopurine methyltransferse status in rheumatology patients receiving azathiopurine
-
Clunie GP, Lennard L. Relevance of thiopurine methyltransferse status in rheumatology patients receiving azathiopurine. Rheumatology 2004;43:13-8.
-
(2004)
Rheumatology
, vol.43
, pp. 13-18
-
-
Clunie, G.P.1
Lennard, L.2
-
7
-
-
20444445901
-
Measurement of thiopurine methyl transferase activity guides dose-initiation and prevents toxicity from azathiopurine
-
Sies C, Florkowski C, George P, et al. Measurement of thiopurine methyl transferase activity guides dose-initiation and prevents toxicity from azathiopurine. N Z Med J 2005;118:U1324.
-
(2005)
N Z Med J
, vol.118
-
-
Sies, C.1
Florkowski, C.2
George, P.3
-
8
-
-
1242297064
-
Pharmacoeconomic analysis of thiopurine methyltransferase polymorphism screening by polymerase chain reaction for treatment with azathioprine in Korea
-
Oh KT, Anis AH, Bae SC. Pharmacoeconomic analysis of thiopurine methyltransferase polymorphism screening by polymerase chain reaction for treatment with azathioprine in Korea. Rheumatology 2004;43:156-63.
-
(2004)
Rheumatology
, vol.43
, pp. 156-163
-
-
Oh, K.T.1
Anis, A.H.2
Bae, S.C.3
-
9
-
-
0031022595
-
Thiopurine methyl transferase levels should be measured before commencing patients on azathiopurine
-
Jackson AP, Hall AG, McLelland J. Thiopurine methyl transferase levels should be measured before commencing patients on azathiopurine. Br J Dermatol 1997;136:133-4.
-
(1997)
Br J Dermatol
, vol.136
, pp. 133-134
-
-
Jackson, A.P.1
Hall, A.G.2
McLelland, J.3
-
10
-
-
4644241129
-
Cost-effectiveness of thiopurine methyltransferase genotype screening in patients about to commence azathiopurine therapy for inflammatory bowel disease
-
Winter J, Walker A, Shapiro D, et al. Cost-effectiveness of thiopurine methyltransferase genotype screening in patients about to commence azathiopurine therapy for inflammatory bowel disease. Aliment Pharmacol Ther 2004;20:593-9.
-
(2004)
Aliment Pharmacol Ther
, vol.20
, pp. 593-599
-
-
Winter, J.1
Walker, A.2
Shapiro, D.3
|